Michael I. Robson

Michael I. Robson

Auto-generated profile, based on publicly available information

Michael I. Robson

Max-Delbrück-Center for Molecular Medicine in the Helmholtz Association (MDC), Berlin Institute for Medical Systems Biology (BIMSB), Chromatin (dys)function in disease group , Berlin, 10115

Research Focus & Metrics

Academic Career Length

16Years (2011-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
16 November 2020 in Nature Communications
Verified
Journal Article
Open access
PDF file
KHKonstantin Helmsauer
Konstantin Helmsauer
M(Maria Stefanova (Valieva)
Maria Stefanova (Valieva)
SASalaheddine Ali
Salaheddine Ali
RGRocío Chamorro González
Rocío Chamorro González
RSRobert Schöpflin
Robert Schöpflin
RKRichard P. Koche
Richard P. Koche
MYCN amplification drives one in six cases of neuroblastoma. The supernumerary gene copies are commonly found on highly rearranged, extrachromosomal circular DNA (ecDNA). The exact amplicon structure has not been described thus far and the functional relevance of its rearrangements is unknown. Here, we analyze the MYCN amplicon structure using short-read and Nanopore sequencing and its chromatin landscape using ChIP-seq, ATAC-seq and Hi-C. This reveals two distinct classes of amplicons which explain the regulatory requirements for MYCN overexpression. The first class always co-amplifies a proximal enhancer driven by the noradrenergic core regulatory circuit (CRC). The second class of MYCN amplicons is characterized by high structural complexity, lacks key local enhancers, and instead contains distal chromosomal fragments harboring CRC-driven enhancers. Thus, ectopic enhancer hijacking can compensate for the loss of local gene regulatory elements and explains a large component of the structural diversity observed in MYCN amplification.

1 June 2019 in Molecular Cell
Verified
Journal Article
Closed access
MRMichael I. Robson
Michael I. Robson
ARAlessa R. Ringel
Alessa R. Ringel
SMStefan Mundlos
Stefan Mundlos

1 June 2016 in Molecular Cell
Verified
Journal Article
Open access
MRMichael I. Robson
Michael I. Robson
JHJose I. de Las Heras
Jose I. de Las Heras
RCRafal Czapiewski
Rafal Czapiewski
PTPhú Lê Thành
Phú Lê Thành
DBDaniel G. Booth
Daniel G. Booth
ESEric Schirmer
Eric Schirmer
Whether gene repositioning to the nuclear periphery during differentiation adds another layer of regulation to gene expression remains controversial. Here, we resolve this by manipulating gene positions through targeting the nuclear envelope transmembrane proteins (NETs) that direct their normal repositioning during myogenesis. Combining transcriptomics with high-resolution DamID mapping of nuclear envelope-genome contacts, we show that three muscle-specific NETs, NET39, Tmem38A, and WFS1, direct specific myogenic genes to the nuclear periphery to facilitate their repression. Retargeting a NET39 fragment to nucleoli correspondingly repositioned a target gene, indicating a direct tethering mechanism. Being able to manipulate gene position independently of other changes in differentiation revealed that repositioning contributes ⅓ to ⅔ of a gene's normal repression in myogenesis. Together, these NETs affect 37% of all genes changing expression during myogenesis, and their combined knockdown almost completely blocks myotube formation. This unequivocally demonstrates that NET-directed gene repositioning is critical for developmental gene regulation.

2 February 2015 in Genome Research
Verified
Journal Article
Open access
PDF file
XAXabier Agirre
Xabier Agirre
GCGiancarlo Castellano
Giancarlo Castellano
MPMarien Pascual
Marien Pascual
SHSimon Heath
Simon Heath
MKMarta Kulis
Marta Kulis
JMJosé I. Martín-Subero
José I. Martín-Subero
While analyzing the DNA methylome of multiple myeloma (MM), a plasma cell neoplasm, by whole-genome bisulfite sequencing and high-density arrays, we observed a highly heterogeneous pattern globally characterized by regional DNA hypermethylation embedded in extensive hypomethylation. In contrast to the widely reported DNA hypermethylation of promoter-associated CpG islands (CGIs) in cancer, hypermethylated sites in MM, as opposed to normal plasma cells, were located outside CpG islands and were unexpectedly associated with intronic enhancer regions defined in normal B cells and plasma cells. Both RNA-seq and in vitro reporter assays indicated that enhancer hypermethylation is globally associated with down-regulation of its host genes. ChIP-seq and DNase-seq further revealed that DNA hypermethylation in these regions is related to enhancer decommissioning. Hypermethylated enhancer regions overlapped with binding sites of B cell-specific transcription factors (TFs) and the degree of enhancer methylation inversely correlated with expression levels of these TFs in MM. Furthermore, hypermethylated regions in MM were methylated in stem cells and gradually became demethylated during normal B-cell differentiation, suggesting that MM cells either reacquire epigenetic features of undifferentiated cells or maintain an epigenetic signature of a putative myeloma stem cell progenitor. Overall, we have identified DNA hypermethylation of developmentally regulated enhancers as a new type of epigenetic modification associated with the pathogenesis of MM.

19 April 2017 in Genome Research
Verified
Journal Article
Open access
PDF file
MRMichael I. Robson
Michael I. Robson
JHJose I. de Las Heras
Jose I. de Las Heras
RCRafal Czapiewski
Rafal Czapiewski
ASAishwarya Sivakumar
Aishwarya Sivakumar
AKAlastair Kerr
Alastair Kerr
ESEric Schirmer
Eric Schirmer
The 3D organization of the genome changes concomitantly with expression changes during hematopoiesis and immune activation. Studies have focused either on lamina-associated domains (LADs) or on topologically associated domains (TADs), defined by preferential local chromatin interactions, and chromosome compartments, defined as higher-order interactions between TADs sharing functionally similar states. However, few studies have investigated how these affect one another. To address this, we mapped LADs using Lamin B1–DamID during Jurkat T-cell activation, finding significant genome reorganization at the nuclear periphery dominated by release of loci frequently important for T-cell function. To assess how these changes at the nuclear periphery influence wider genome organization, our DamID data sets were contrasted with TADs and compartments. Features of specific repositioning events were then tested by fluorescence in situ hybridization during T-cell activation. First, considerable overlap between TADs and LADs was observed with the TAD repositioning as a unit. Second, A1 and A2 subcompartments are segregated in 3D space through differences in proximity to LADs along chromosomes. Third, genes and a putative enhancer in LADs that were released from the periphery during T-cell activation became preferentially associated with A2 subcompartments and were constrained to the relative proximity of the lamina. Thus, lamina associations influence internal nuclear organization, and changes in LADs during T-cell activation may provide an important additional mode of gene regulation.

10 February 2021 in Nature
Verified
Journal Article
Closed access
PDF file
LALila Allou
Lila Allou
SBSara Balzano
Sara Balzano
AMAndreas Magg
Andreas Magg
MQMathieu Quinodoz
Mathieu Quinodoz
BRBeryl Royer-Bertrand
Beryl Royer-Bertrand
ASAndrea Superti-Furga
Andrea Superti-Furga